Thursday, 23 April 2026
  
Login

Australia's most trusted
source of pharma news

Thursday, 23 April 2026
News

Aussie pharma naughty or nice?

Posted 23 April 2026 AM

Despite more than 10 Code of Conduct complaints in three years resulting in more than $1.3 million in fines, Australia has a well-behaved pharma industry that closely follows ethical guidelines, compared to other countries.

Medicines Australia's Code of Conduct Committee was called on to invesigate 11 alleged breaches of the Code resulting in $1.325 million in combined fines. In contrast, the UK's Prescription Medicines Code of Practice Authority ruled on 287 alleged code breaches over the past three years.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (6)

Sales & Customer Relations (15)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (3)

Other (9)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.